• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的 RNA 编辑会影响免疫反应途径中 mRNA 的丰度。

RNA editing in cancer impacts mRNA abundance in immune response pathways.

机构信息

Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA.

Molecular, Cellular and Integrative Physiology Interdepartmental Program, UCLA, Los Angeles, CA, USA.

出版信息

Genome Biol. 2020 Oct 26;21(1):268. doi: 10.1186/s13059-020-02171-4.

DOI:10.1186/s13059-020-02171-4
PMID:33106178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7586670/
Abstract

BACKGROUND

RNA editing generates modifications to the RNA sequences, thereby increasing protein diversity and shaping various layers of gene regulation. Recent studies have revealed global shifts in editing levels across many cancer types, as well as a few specific mechanisms implicating individual sites in tumorigenesis or metastasis. However, most tumor-associated sites, predominantly in noncoding regions, have unknown functional relevance.

RESULTS

Here, we carry out integrative analysis of RNA editing profiles between epithelial and mesenchymal tumors, since epithelial-mesenchymal transition is a key paradigm for metastasis. We identify distinct editing patterns between epithelial and mesenchymal tumors in seven cancer types using TCGA data, an observation further supported by single-cell RNA sequencing data and ADAR perturbation experiments in cell culture. Through computational analyses and experimental validations, we show that differential editing sites between epithelial and mesenchymal phenotypes function by regulating mRNA abundance of their respective genes. Our analysis of RNA-binding proteins reveals ILF3 as a potential regulator of this process, supported by experimental validations. Consistent with the known roles of ILF3 in immune response, epithelial-mesenchymal differential editing sites are enriched in genes involved in immune and viral processes. The strongest target of editing-dependent ILF3 regulation is the transcript encoding PKR, a crucial player in immune and viral response.

CONCLUSIONS

Our study reports widespread differences in RNA editing between epithelial and mesenchymal tumors and a novel mechanism of editing-dependent regulation of mRNA abundance. It reveals the broad impact of RNA editing in cancer and its relevance to cancer-related immune pathways.

摘要

背景

RNA 编辑会对 RNA 序列进行修饰,从而增加蛋白质的多样性,并塑造各种基因调控层次。最近的研究揭示了许多癌症类型中编辑水平的全局变化,以及一些涉及个别位点在肿瘤发生或转移中的特定机制。然而,大多数与肿瘤相关的位点主要位于非编码区域,其功能相关性尚不清楚。

结果

在这里,我们对上皮和间充质肿瘤的 RNA 编辑谱进行了综合分析,因为上皮-间充质转化是转移的关键范例。我们使用 TCGA 数据在七种癌症类型中识别出上皮和间充质肿瘤之间的不同编辑模式,这一观察结果进一步得到单细胞 RNA 测序数据和细胞培养中 ADAR 扰动实验的支持。通过计算分析和实验验证,我们表明上皮和间充质表型之间的差异编辑位点通过调节各自基因的 mRNA 丰度起作用。我们对 RNA 结合蛋白的分析表明,ILF3 可能是这个过程的调节剂,实验验证也支持了这一观点。与 ILF3 在免疫反应中的已知作用一致,上皮-间充质差异编辑位点富集在参与免疫和病毒过程的基因中。编辑依赖性 ILF3 调节的最强靶标是编码 PKR 的转录本,PKR 是免疫和病毒反应中的关键参与者。

结论

我们的研究报告了上皮和间充质肿瘤之间广泛存在的 RNA 编辑差异,以及一种新的基于编辑的 mRNA 丰度调节机制。它揭示了 RNA 编辑在癌症中的广泛影响及其与癌症相关免疫途径的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/f3b1a9cbc370/13059_2020_2171_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/65ff19247bc8/13059_2020_2171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/78da55298264/13059_2020_2171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/fb2b11638bd3/13059_2020_2171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/2ab3f4674c69/13059_2020_2171_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/eb7853807ca3/13059_2020_2171_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/24319856fe82/13059_2020_2171_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/f3b1a9cbc370/13059_2020_2171_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/65ff19247bc8/13059_2020_2171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/78da55298264/13059_2020_2171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/fb2b11638bd3/13059_2020_2171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/2ab3f4674c69/13059_2020_2171_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/eb7853807ca3/13059_2020_2171_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/24319856fe82/13059_2020_2171_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/7586670/f3b1a9cbc370/13059_2020_2171_Fig7_HTML.jpg

相似文献

1
RNA editing in cancer impacts mRNA abundance in immune response pathways.癌症中的 RNA 编辑会影响免疫反应途径中 mRNA 的丰度。
Genome Biol. 2020 Oct 26;21(1):268. doi: 10.1186/s13059-020-02171-4.
2
Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.无偏鉴定 ADAR 和 A-to-I RNA 编辑的反式调控因子。
Cell Rep. 2020 May 19;31(7):107656. doi: 10.1016/j.celrep.2020.107656.
3
In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.在癌症中,A-to-I RNA 编辑可能是驱动因素、乘客或机制。
Drug Resist Updat. 2017 May;32:16-22. doi: 10.1016/j.drup.2017.09.001. Epub 2017 Oct 4.
4
Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.组合 RNA 测序分析揭示 ADAR1 在胃癌中双重调控基因的模式。
Dig Dis Sci. 2018 Jul;63(7):1835-1850. doi: 10.1007/s10620-018-5081-9. Epub 2018 Apr 25.
5
Structure-mediated modulation of mRNA abundance by A-to-I editing.结构介导的 A-to-I 编辑对 mRNA 丰度的调节。
Nat Commun. 2017 Nov 2;8(1):1255. doi: 10.1038/s41467-017-01459-7.
6
Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).RNA 腺苷脱氨酶作用下的可变剪接的全球调控(ADAR)。
RNA. 2013 May;19(5):591-604. doi: 10.1261/rna.038042.112. Epub 2013 Mar 8.
7
Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.作用于RNA 3的腺苷脱氨酶(ADAR3)与胶质母细胞瘤中谷氨酸受体亚基B前体mRNA结合可抑制RNA编辑 。
J Biol Chem. 2017 Mar 10;292(10):4326-4335. doi: 10.1074/jbc.M117.779868. Epub 2017 Feb 6.
8
A-to-I RNA editing as a tuner of noncoding RNAs in cancer.A-to-I RNA 编辑作为癌症中非编码 RNA 的调节剂。
Cancer Lett. 2020 Dec 1;494:88-93. doi: 10.1016/j.canlet.2020.08.004. Epub 2020 Aug 19.
9
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.肺腺癌中 ADAR 对 RNA 丰度调控的全转录组分析。
EBioMedicine. 2018 Jan;27:167-175. doi: 10.1016/j.ebiom.2017.12.005. Epub 2017 Dec 6.
10
ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.ADAR1 介导的乳腺癌 3'UTR 的 RNA 编辑。
Biol Res. 2018 Oct 5;51(1):36. doi: 10.1186/s40659-018-0185-4.

引用本文的文献

1
A novel adenosine-to-inosine RNA editing-based nomogram for predicting prognosis of hepatocellular carcinoma.一种基于新型腺苷到肌苷RNA编辑的列线图,用于预测肝细胞癌的预后。
Front Pharmacol. 2025 May 14;16:1547320. doi: 10.3389/fphar.2025.1547320. eCollection 2025.
2
Hippocampal adenosine-to-inosine RNA editing in sepsis: dynamic changes and influencing factors.脓毒症中海马体腺苷到次黄嘌呤的RNA编辑:动态变化及影响因素
Brain Commun. 2024 Aug 8;6(4):fcae260. doi: 10.1093/braincomms/fcae260. eCollection 2024.
3
ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer.

本文引用的文献

1
Statistical inference of differential RNA-editing sites from RNA-sequencing data by hierarchical modeling.基于层次模型的 RNA 测序数据分析差异 RNA 编辑位点的统计推断。
Bioinformatics. 2020 May 1;36(9):2796-2804. doi: 10.1093/bioinformatics/btaa066.
2
The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing.RNA 结合蛋白 AKAP8 通过拮抗 EMT 相关的可变剪接抑制肿瘤转移。
Nat Commun. 2020 Jan 24;11(1):486. doi: 10.1038/s41467-020-14304-1.
3
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression.
ADAR 介导的 A>I(G) RNA 编辑在乳腺癌的致瘤药物反应中的作用。
Int J Mol Sci. 2024 Jul 6;25(13):7424. doi: 10.3390/ijms25137424.
4
Effects of the glyphosate-based herbicide roundup on C. elegans and S. cerevisiae mortality, reproduction, and transcription fidelity.草甘膦除草剂对秀丽隐杆线虫和酿酒酵母死亡率、繁殖能力和转录保真度的影响。
Environ Pollut. 2024 Sep 1;356:124203. doi: 10.1016/j.envpol.2024.124203. Epub 2024 Jun 1.
5
Navigating the landscape of epitranscriptomics and host immunity.解析外显转录组学和宿主免疫的领域。
Genome Res. 2024 May 15;34(4):515-529. doi: 10.1101/gr.278412.123.
6
A single-cell atlas of West African lungfish respiratory system reveals evolutionary adaptations to terrestrialization.西非肺鱼呼吸系统单细胞图谱揭示了其对陆地化的进化适应。
Nat Commun. 2023 Sep 13;14(1):5630. doi: 10.1038/s41467-023-41309-3.
7
Host-mediated RNA editing in viruses.病毒中的宿主介导的 RNA 编辑。
Biol Direct. 2023 Mar 28;18(1):12. doi: 10.1186/s13062-023-00366-w.
8
Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas.预后性RNA编辑特征可预测神经胶质瘤的免疫功能和治疗反应。
Front Genet. 2023 Feb 8;14:1120354. doi: 10.3389/fgene.2023.1120354. eCollection 2023.
9
The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition.胸膜间皮瘤上皮-间充质转化过程中 RNA 编辑变化模式。
Int J Mol Sci. 2023 Feb 2;24(3):2874. doi: 10.3390/ijms24032874.
10
Lactobacillus for ribosome peptide editing cancer.乳杆菌用于核糖体肽编辑癌症。
Clin Transl Oncol. 2023 Jun;25(6):1522-1544. doi: 10.1007/s12094-022-03066-5. Epub 2023 Jan 24.
使用正则化负二项式回归进行单细胞 RNA-seq 数据的归一化和方差稳定化。
Genome Biol. 2019 Dec 23;20(1):296. doi: 10.1186/s13059-019-1874-1.
4
Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion.Ran 促进 RhoA 的膜靶向和稳定,以协调卵巢癌细胞的侵袭。
Nat Commun. 2019 Jun 17;10(1):2666. doi: 10.1038/s41467-019-10570-w.
5
Comprehensive Integration of Single-Cell Data.单细胞数据的综合整合。
Cell. 2019 Jun 13;177(7):1888-1902.e21. doi: 10.1016/j.cell.2019.05.031. Epub 2019 Jun 6.
6
Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.非编码腺嘌呤到肌苷RNA编辑在多种人类癌症中的临床相关性
JCO Clin Cancer Inform. 2019 Jun;3:1-8. doi: 10.1200/CCI.18.00151.
7
Determining cell type abundance and expression from bulk tissues with digital cytometry.利用数字细胞术从组织样本中测定细胞类型丰度和表达。
Nat Biotechnol. 2019 Jul;37(7):773-782. doi: 10.1038/s41587-019-0114-2. Epub 2019 May 6.
8
ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors.ADAR1 通过对多种 HIF-1α 抑制因子的不同调节促进强大的低氧信号传导。
EMBO Rep. 2019 May;20(5). doi: 10.15252/embr.201847107. Epub 2019 Apr 4.
9
Allele-specific binding of RNA-binding proteins reveals functional genetic variants in the RNA.RNA 结合蛋白的等位基因特异性结合揭示了 RNA 中的功能遗传变异。
Nat Commun. 2019 Mar 22;10(1):1338. doi: 10.1038/s41467-019-09292-w.
10
PKR: A Kinase to Remember.PKR:一个值得铭记的激酶。
Front Mol Neurosci. 2019 Jan 9;11:480. doi: 10.3389/fnmol.2018.00480. eCollection 2018.